Breaking News

You are here » Indian-Commodity  :  Top News  :  Suven Life Sciences secures product patents in New Zealand, Norway

22-May2018

Suven Life Sciences secures product patents in New Zealand, Norway

Suven Life Sciences has secured one product patent from New Zealand and one product patent from Norway corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2034 and 2027 respectively.

The granted claims of the patents include the class of selective 5HT6 compounds and are being developed as therapeutic agents for major depressive disorders and for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia respectively.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.



Related News

View all news

Copper futures end tad higher on Monday

Copper futures ended slightly higher on Monday, with hopes of a resolution to the US-China trade war outweighing the threat of higher US tariffs on Chinese goods. Copper prices improved further as the......

Gold futures extend winning streak to fourth straight session on Monday

Gold futures extended winning streak to fourth straight session by registering small gains on Monday, amid geopolitical uncertainty and an eased greenback. However, gains were limited due to thin volume......

Physical Rubber prices witness weakness on Monday

Physical Rubber prices showed weakness on Monday amidst dull volumes in the market. Spot prices for RSS-4 variety fell to Rs 120.50/ kg compared to its previous closing of Rs 121/ kg; while the RSS-5 variety......

Top News

View all news

Jumbo Finance gets shareholders' nod to increase borrowing limits up to Rs 30 crore

Jumbo Finance has received an approval to increase Borrowing Limits of the company up-to Rs 30 crore. The shareholders of the company at their meeting held on November 19, 2018, approved the same.Jumbo......

Alembic Pharma gets USFDA's nod for Vardenafil Hydrochloride Orally Disintegrating Tablets

Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Vardenafil Hydrochloride Orally Disintegrating Tablets,......

SRF expects total Rs 28 crore quantum of damage due to Cyclone GAJA

SRF is expecting a total Rs 28 crore quantum of damage caused, based on the initial assessment. The disruption of operations was due to Cyclone GAJA at the plant of Technical Textiles Business (Viralimalai)......